Correlation Between Tilray and Zomedica Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Tilray and Zomedica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tilray and Zomedica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tilray Inc and Zomedica Pharmaceuticals Corp, you can compare the effects of market volatilities on Tilray and Zomedica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tilray with a short position of Zomedica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tilray and Zomedica Pharmaceuticals.

Diversification Opportunities for Tilray and Zomedica Pharmaceuticals

0.68

Correlation Coefficient

Tilray  Zomedica Pharmaceuticals

Poor diversification

The 3 months correlation between Tilray and Zomedica is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Tilray Inc and Zomedica Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zomedica Pharmaceuticals and Tilray is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tilray Inc are associated (or correlated) with Zomedica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zomedica Pharmaceuticals has no effect on the direction of Tilray i.e., Tilray and Zomedica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Tilray and Zomedica Pharmaceuticals

Given the investment horizon of 90 days Tilray Inc is expected to under-perform the Zomedica Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Tilray Inc is 2.32 times less risky than Zomedica Pharmaceuticals. The stock trades about -0.2 of its potential returns per unit of risk. The Zomedica Pharmaceuticals Corp is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  13.00  in Zomedica Pharmaceuticals Corp on December 20, 2024 and sell it today you would lose (5.30) from holding Zomedica Pharmaceuticals Corp or give up 40.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tilray Inc  vs.  Zomedica Pharmaceuticals Corp

Tilray Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tilray Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Zomedica Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zomedica Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Tilray and Zomedica Pharmaceuticals

The main advantage of trading using opposite Tilray and Zomedica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tilray position performs unexpectedly, Zomedica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zomedica Pharmaceuticals will offset losses from the drop in Zomedica Pharmaceuticals' long position.

The idea behind Tilray Inc and Zomedica Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.